Taken together, these data demonstrate that Ewing sarcomas developed in an immunocompetent, humanized murine model have increased expression of important modulators of the TME, including TGFβ1, and increased metastatic potential as compared with tumors developed in NSG, immunodeficient models. This evidence concerns the gene TGFB1 and Ewing sarcoma.